These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4859445)

  • 1. Polysynaptic spinal reflexes in Parkinson's disease.
    Delwaide PJ; Schwab RS; Young RR
    Neurology; 1974 Sep; 24(9):820-7. PubMed ID: 4859445
    [No Abstract]   [Full Text] [Related]  

  • 2. Habituation of blink reflexes in parkinsonian patients under levodopa and amantadine treatment.
    Messina C; Di Rosa AE; Tomasello F
    J Neurol Sci; 1972 Oct; 17(2):141-8. PubMed ID: 4340932
    [No Abstract]   [Full Text] [Related]  

  • 3. Impaired potentiation of H-reflexes in patients with Parkinson's disease.
    Sica RE; Aguilera N; Herskovits E
    Medicina (B Aires); 1972; 32(6):588-95. PubMed ID: 4663253
    [No Abstract]   [Full Text] [Related]  

  • 4. An electrophysiological study of some trigeminofacial reflexes in Parkinson's disease before and after L-dopam administration.
    Caccia MR; Avanzini G; Negri S
    Eur Neurol; 1972; 8(6):339-51. PubMed ID: 5087019
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of Parkinson's disease with amantadine and L-Dopa.
    Rinne UK; Sonninen V; Siirtola T
    Eur Neurol; 1972; 7(4):228-40. PubMed ID: 4556618
    [No Abstract]   [Full Text] [Related]  

  • 6. Amantadine and levodopa in the treatment of Parkinson's disease.
    Walker JE; Potvin A; Tourtellotte W; Albers J; Repa B; Henderson W; Snyder D
    Clin Pharmacol Ther; 1972; 13(1):28-36. PubMed ID: 4550321
    [No Abstract]   [Full Text] [Related]  

  • 7. [Modern therapeutics of Parkinson's disease].
    Schott B
    Lyon Med; 1971 Nov; 226(17):539-46. PubMed ID: 5134684
    [No Abstract]   [Full Text] [Related]  

  • 8. Blink reflex studies in patients with Parkinsonism before and during therapy.
    Penders CA; Delwaide PJ
    J Neurol Neurosurg Psychiatry; 1971 Dec; 34(6):674-8. PubMed ID: 5158781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of L-dopa or amantadine therapy on sleep spindles in Parkinsonism.
    Puca FM; Bricolo A; Turella G
    Electroencephalogr Clin Neurophysiol; 1973 Sep; 35(3):327-30. PubMed ID: 4126184
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-latency myotatic reflexes in man: mechanisms, functional significance, and changes in patients with Parkinson's disease or hemiplegia.
    Lee RG; Murphy JT; Tatton WG
    Adv Neurol; 1983; 39():489-508. PubMed ID: 6419555
    [No Abstract]   [Full Text] [Related]  

  • 11. [Electromyographic aspects of laro-dopa therapy].
    Càmpeanu E; Mareş V; Dumitru E; Kory S
    Neurol Psihiatr Neurochir; 1973; 18(6):551-8. PubMed ID: 4790487
    [No Abstract]   [Full Text] [Related]  

  • 12. Amantadine for Parkinson's disease.
    Mann DC; Pearce LA; Waterbury LD
    Neurology; 1971 Sep; 21(9):958-62. PubMed ID: 4936828
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of amantadine, placebo, and levodopa in Parkinson's disease.
    Bauer RB; McHenry JT
    Neurology; 1974 Aug; 24(8):715-20. PubMed ID: 4858417
    [No Abstract]   [Full Text] [Related]  

  • 14. Muscle silent period in Parkinson's disease.
    Higgins DC; Haidri NH; Wilbourn AJ
    J Neurol Neurosurg Psychiatry; 1971 Oct; 34(5):508-11. PubMed ID: 4256387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
    Sigwald J; Raymondeaud C; Piot C
    Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
    [No Abstract]   [Full Text] [Related]  

  • 16. [Action of amantadine HCl alone and in combination with L-dopa on parkinsonism].
    Danielczyk W; Korten JJ
    Med Monatsschr; 1971 Oct; 25(10):472-9. PubMed ID: 5122447
    [No Abstract]   [Full Text] [Related]  

  • 17. L-dopa and amantadine hydrochloride in Parkinson's disease.
    Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects induced by the treatment with amantadine on habituation of trigemino-facial reflexes in Parkinsonian patients].
    Messina C; Tomasello F
    Riv Neurol; 1972; 42(2):202-8. PubMed ID: 4341955
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug therapy of Parkinson's disease with amantadine and levodopa].
    Fieschi C; Nardini M; Casacchia M; Reitano M; Tedone ME; Ferrari P; Robotti E
    Sist Nerv; 1970; 22(2):126-43. PubMed ID: 5504552
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prolonged treatment of Parkinson's disease with amantadine and L-Dopa].
    Fieschi C; Casacchia M; Nardini M; Reitano N
    Minerva Med; 1971 Oct; 62(82):4040-2. PubMed ID: 5125075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.